Bio-Techne Releases First Quarter Fiscal 2022 Results
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2021. First Quarter FY2022...
Stay updated with breaking news from Chuck Kummeth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2021. First Quarter FY2022...
BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2022 RESULTS Minneapolis/November 2, 2021/ Bio-Techne Corporation today reported its financial results for the first quarter ended... | November 2, 2021
TECH earnings call for the period ending September 30, 2021.
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has published important clinical research in...
Share this article - COVID-SeroKlir detects both the presence and precise level of neutralizing IgG antibodies with 98.8% sensitivity and 99.6% specificity- -Available immediately and can be used in Canadian laboratories without proprietary equipment- NEW YORK, June 2, 2021 /PRNewswire/ -- Kantaro Biosciences, LLC (Kantaro), a joint venture between the Mount Sinai Health System and RenalytixAI (LSE: RENS /NASDAQ: RNLX), and its commercial partner Bio-Techne Corporation (NASDAQ: TECH), have received Health Canada Authorization under the COVID-19 Interim Order for COVID-SeroKlir, its semi-q...